【RNA】「Genialis™ krasID」: 可預測病患對「KRAS」抑制劑在組織學和突變的反應與效益

 【RNA】「Genialis™ krasID」: 可預測病患對「KRAS」抑制劑在組織學和突變的反應與臨床效益

 文章出處  

Businesswire 

 

 原文標題  

Genialis Launches First-in-Class Biomarker to Predict Tumor Response and Clinical Benefit to KRAS Inhibitors 

 

 Twitter  

https://x.com/aimedadviser/status/1839454323203285432 

 

 文章序號  

6333 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.